| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $8,574,894,019 | 44,554,162 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,252,083,986 | 36,178,056 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $2,080,564,335 | 11,668,897 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $1,026,607,457 | 42,864,612 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $356,921,103 | 1,545,113 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $330,272,297 | 3,810,248 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $151,143,031 | 2,520,731 | SOLE | |||
| Invitae Corporation | Note 1.5% 4/1/2028 | 46185LAD5 | $135,000,000 | 300,000,000 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $119,442,381 | 17,310,490 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $110,579,569 | 2,368,378 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $109,186,367 | 280,159 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $107,156,423 | 6,498,267 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $106,307,662 | 4,578,280 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $106,268,163 | 16,450,180 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $100,589,067 | 4,375,340 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $95,040,207 | 9,428,592 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $89,484,159 | 12,710,818 | SOLE | |||
| SpringWorks Therapeutics, Inc. | COM | 85205L107 | $78,655,962 | 2,999,846 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $73,668,500 | 4,865,819 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $71,997,438 | 2,691,493 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $65,095,017 | 5,640,816 | SOLE | |||
| Chinook Therapeutics, Inc. | COM | 16961L106 | $55,908,861 | 1,455,202 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $50,935,496 | 1,409,784 | SOLE | |||
| DICE Therapeutics, Inc. | COM | 23345J104 | $48,122,618 | 1,035,786 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $46,291,431 | 2,108,949 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $45,557,208 | 10,123,824 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $42,946,552 | 1,455,322 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $39,558,844 | 2,809,577 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $39,526,193 | 16,067,558 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $38,782,429 | 3,882,125 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $36,122,512 | 783,059 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $33,673,665 | 1,963,479 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $29,141,048 | 3,157,210 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $28,938,102 | 751,639 | SOLE | |||
| ImmunoGen, Inc. | COM | 45253H101 | $28,684,230 | 1,520,097 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $27,767,102 | 14,614,264 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $26,559,938 | 1,416,530 | SOLE | |||
| 2seventy bio, Inc. | COMMON STOCK | 901384107 | $25,274,963 | 2,497,526 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $24,959,891 | 1,062,123 | SOLE | |||
| Stoke Therapeutics, Inc. | COM | 86150R107 | $22,644,430 | 2,130,238 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $21,534,133 | 843,814 | SOLE | |||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $20,714,064 | 3,023,951 | SOLE | |||
| Cabaletta Bio, Inc. | COM | 12674W109 | $20,578,540 | 1,594,000 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $19,950,252 | 169,934 | SOLE | |||
| Summit Therapeutics Inc. | COM | 86627T108 | $15,824,810 | 6,304,705 | SOLE | |||
| AnaptysBio, Inc. | COM | 32724106 | $15,782,294 | 775,924 | SOLE | |||
| Prime Medicine, Inc. | COM | 74168J101 | $15,067,027 | 1,028,466 | SOLE | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | $14,999,501 | 1,127,782 | SOLE | |||
| Relay Therapeutics, Inc. | COM | 75943R102 | $14,571,070 | 1,160,117 | SOLE | |||
| ARS Pharmaceuticals, Inc. | COM | 82835W108 | $13,443,222 | 2,006,451 | SOLE |